This pipeline uses various statistical tests to identify miRs whose log2 expression levels correlated to selected clinical features.
Testing the association between 544 miRs and 11 clinical features across 358 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 8 clinical features related to at least one miRs.
-
30 miRs correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.
-
HSA-MIR-149 , HSA-MIR-3677 , HSA-MIR-23C , HSA-MIR-489 , HSA-MIR-632 , ...
-
30 miRs correlated to 'YEARS_TO_BIRTH'.
-
HSA-MIR-1269 , HSA-MIR-200C , HSA-MIR-483 , HSA-MIR-412 , HSA-MIR-296 , ...
-
22 miRs correlated to 'NEOPLASM_DISEASESTAGE'.
-
HSA-MIR-23C , HSA-MIR-550A-1 , HSA-MIR-139 , HSA-MIR-7-2 , HSA-MIR-642A , ...
-
30 miRs correlated to 'PATHOLOGY_T_STAGE'.
-
HSA-MIR-23C , HSA-MIR-139 , HSA-MIR-550A-1 , HSA-MIR-149 , HSA-MIR-122 , ...
-
30 miRs correlated to 'GENDER'.
-
HSA-MIR-26A-2 , HSA-MIR-375 , HSA-MIR-1301 , HSA-MIR-331 , HSA-MIR-106A , ...
-
30 miRs correlated to 'HISTOLOGICAL_TYPE'.
-
HSA-MIR-194-1 , HSA-MIR-194-2 , HSA-MIR-192 , HSA-MIR-10A , HSA-MIR-122 , ...
-
30 miRs correlated to 'RACE'.
-
HSA-MIR-23C , HSA-MIR-3130-1 , HSA-MIR-532 , HSA-MIR-30D , HSA-MIR-511-1 , ...
-
2 miRs correlated to 'ETHNICITY'.
-
HSA-MIR-508 , HSA-MIR-514-3
-
No miRs correlated to 'PATHOLOGY_N_STAGE', 'PATHOLOGY_M_STAGE', and 'COMPLETENESS_OF_RESECTION'.
Complete statistical result table is provided in Supplement Table 1
Table 1. Get Full Table This table shows the clinical features, statistical methods used, and the number of miRs that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.
Clinical feature | Statistical test | Significant miRs | Associated with | Associated with | ||
---|---|---|---|---|---|---|
DAYS_TO_DEATH_OR_LAST_FUP | Cox regression test | N=30 | shorter survival | N=28 | longer survival | N=2 |
YEARS_TO_BIRTH | Spearman correlation test | N=30 | older | N=5 | younger | N=25 |
NEOPLASM_DISEASESTAGE | Kruskal-Wallis test | N=22 | ||||
PATHOLOGY_T_STAGE | Spearman correlation test | N=30 | higher stage | N=24 | lower stage | N=6 |
PATHOLOGY_N_STAGE | Wilcoxon test | N=0 | ||||
PATHOLOGY_M_STAGE | Wilcoxon test | N=0 | ||||
GENDER | Wilcoxon test | N=30 | male | N=30 | female | N=0 |
HISTOLOGICAL_TYPE | Kruskal-Wallis test | N=30 | ||||
COMPLETENESS_OF_RESECTION | Kruskal-Wallis test | N=0 | ||||
RACE | Kruskal-Wallis test | N=30 | ||||
ETHNICITY | Wilcoxon test | N=2 | not hispanic or latino | N=2 | hispanic or latino | N=0 |
Table S1. Basic characteristics of clinical feature: 'DAYS_TO_DEATH_OR_LAST_FUP'
DAYS_TO_DEATH_OR_LAST_FUP | Duration (Months) | 0-120.8 (median=19.3) |
censored | N = 251 | |
death | N = 106 | |
Significant markers | N = 30 | |
associated with shorter survival | 28 | |
associated with longer survival | 2 |
Table S2. Get Full Table List of top 10 miRs significantly associated with 'Time to Death' by Cox regression test
HazardRatio | Wald_P | Q | C_index | |
---|---|---|---|---|
HSA-MIR-149 | 1.37 | 3.833e-06 | 0.0021 | 0.63 |
HSA-MIR-3677 | 1.41 | 1.856e-05 | 0.005 | 0.644 |
HSA-MIR-23C | 0.74 | 2.781e-05 | 0.005 | 0.394 |
HSA-MIR-489 | 1.56 | 6.341e-05 | 0.0056 | 0.635 |
HSA-MIR-632 | 1.71 | 7.506e-05 | 0.0056 | 0.6 |
HSA-MIR-9-1 | 1.18 | 7.826e-05 | 0.0056 | 0.62 |
HSA-MIR-9-2 | 1.18 | 7.996e-05 | 0.0056 | 0.618 |
HSA-MIR-212 | 1.48 | 8.239e-05 | 0.0056 | 0.617 |
HSA-MIR-550A-1 | 1.5 | 0.0001366 | 0.0082 | 0.609 |
HSA-MIR-106A | 1.33 | 0.0001792 | 0.0082 | 0.586 |
Table S3. Basic characteristics of clinical feature: 'YEARS_TO_BIRTH'
YEARS_TO_BIRTH | Mean (SD) | 59.57 (13) |
Significant markers | N = 30 | |
pos. correlated | 5 | |
neg. correlated | 25 |
Table S4. Get Full Table List of top 10 miRs significantly correlated to 'YEARS_TO_BIRTH' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
HSA-MIR-1269 | 0.2607 | 7.352e-07 | 4e-04 |
HSA-MIR-200C | -0.2287 | 1.356e-05 | 0.00369 |
HSA-MIR-483 | -0.2244 | 2.211e-05 | 0.00401 |
HSA-MIR-412 | -0.2207 | 3.724e-05 | 0.00439 |
HSA-MIR-296 | -0.2226 | 4.036e-05 | 0.00439 |
HSA-MIR-181B-1 | -0.2138 | 4.902e-05 | 0.00444 |
HSA-MIR-181A-2 | -0.2109 | 6.2e-05 | 0.00481 |
HSA-MIR-181D | -0.2093 | 7.072e-05 | 0.00481 |
HSA-LET-7E | -0.2078 | 8.022e-05 | 0.00485 |
HSA-MIR-889 | -0.1985 | 0.0001711 | 0.00931 |
Table S5. Basic characteristics of clinical feature: 'NEOPLASM_DISEASESTAGE'
NEOPLASM_DISEASESTAGE | Labels | N |
STAGE I | 166 | |
STAGE II | 83 | |
STAGE III | 3 | |
STAGE IIIA | 61 | |
STAGE IIIB | 8 | |
STAGE IIIC | 9 | |
STAGE IV | 3 | |
STAGE IVA | 1 | |
STAGE IVB | 2 | |
Significant markers | N = 22 |
Table S6. Get Full Table List of top 10 miRs differentially expressed by 'NEOPLASM_DISEASESTAGE'
kruskal_wallis_P | Q | |
---|---|---|
HSA-MIR-23C | 7.392e-05 | 0.0402 |
HSA-MIR-550A-1 | 0.0001764 | 0.048 |
HSA-MIR-139 | 0.0003543 | 0.0551 |
HSA-MIR-7-2 | 0.0004049 | 0.0551 |
HSA-MIR-642A | 0.0006008 | 0.0654 |
HSA-MIR-194-1 | 0.001025 | 0.0902 |
HSA-MIR-194-2 | 0.001161 | 0.0902 |
HSA-MIR-550A-2 | 0.002507 | 0.17 |
HSA-MIR-22 | 0.003189 | 0.193 |
HSA-MIR-346 | 0.003862 | 0.196 |
Table S7. Basic characteristics of clinical feature: 'PATHOLOGY_T_STAGE'
PATHOLOGY_T_STAGE | Mean (SD) | 1.79 (0.91) |
N | ||
T0 | 1 | |
T1 | 176 | |
T2 | 90 | |
T3 | 76 | |
T4 | 13 | |
Significant markers | N = 30 | |
pos. correlated | 24 | |
neg. correlated | 6 |
Table S8. Get Full Table List of top 10 miRs significantly correlated to 'PATHOLOGY_T_STAGE' by Spearman correlation test
SpearmanCorr | corrP | Q | |
---|---|---|---|
HSA-MIR-23C | -0.289 | 1.63e-07 | 4.85e-05 |
HSA-MIR-139 | -0.2724 | 1.784e-07 | 4.85e-05 |
HSA-MIR-550A-1 | 0.2634 | 4.767e-07 | 8.64e-05 |
HSA-MIR-149 | 0.2345 | 8.009e-06 | 0.00109 |
HSA-MIR-122 | -0.2268 | 1.562e-05 | 0.00143 |
HSA-MIR-22 | -0.2264 | 1.615e-05 | 0.00143 |
HSA-MIR-194-1 | -0.2239 | 2.003e-05 | 0.00143 |
HSA-MIR-194-2 | -0.2234 | 2.1e-05 | 0.00143 |
HSA-MIR-550A-2 | 0.2195 | 3.019e-05 | 0.00182 |
HSA-MIR-7-3 | 0.2846 | 0.000103 | 0.0056 |
Table S9. Basic characteristics of clinical feature: 'PATHOLOGY_N_STAGE'
PATHOLOGY_N_STAGE | Labels | N |
N0 | 249 | |
N1 | 4 | |
Significant markers | N = 0 |
Table S10. Basic characteristics of clinical feature: 'PATHOLOGY_M_STAGE'
PATHOLOGY_M_STAGE | Labels | N |
class0 | 263 | |
class1 | 4 | |
Significant markers | N = 0 |
Table S11. Basic characteristics of clinical feature: 'GENDER'
GENDER | Labels | N |
FEMALE | 113 | |
MALE | 245 | |
Significant markers | N = 30 | |
Higher in MALE | 30 | |
Higher in FEMALE | 0 |
Table S12. Get Full Table List of top 10 miRs differentially expressed by 'GENDER'. 0 significant gene(s) located in sex chromosomes is(are) filtered out.
W(pos if higher in 'MALE') | wilcoxontestP | Q | AUC | |
---|---|---|---|---|
HSA-MIR-26A-2 | 9933 | 1.745e-05 | 0.00557 | 0.6412 |
HSA-MIR-375 | 10024 | 2.726e-05 | 0.00557 | 0.6379 |
HSA-MIR-1301 | 10106 | 4.041e-05 | 0.00557 | 0.635 |
HSA-MIR-331 | 10109 | 4.099e-05 | 0.00557 | 0.6349 |
HSA-MIR-106A | 10216 | 6.769e-05 | 0.00736 | 0.631 |
HSA-MIR-363 | 10455 | 0.0001979 | 0.0125 | 0.6224 |
HSA-MIR-182 | 10464 | 0.0002058 | 0.0125 | 0.622 |
HSA-MIR-26A-1 | 10200 | 0.0002108 | 0.0125 | 0.6223 |
HSA-MIR-1266 | 10444 | 0.0002293 | 0.0125 | 0.6212 |
HSA-MIR-183 | 10490 | 0.0002303 | 0.0125 | 0.6211 |
Table S13. Basic characteristics of clinical feature: 'HISTOLOGICAL_TYPE'
HISTOLOGICAL_TYPE | Labels | N |
FIBROLAMELLAR CARCINOMA | 2 | |
HEPATOCELLULAR CARCINOMA | 349 | |
HEPATOCHOLANGIOCARCINOMA (MIXED) | 7 | |
Significant markers | N = 30 |
Table S14. Get Full Table List of top 10 miRs differentially expressed by 'HISTOLOGICAL_TYPE'
kruskal_wallis_P | Q | |
---|---|---|
HSA-MIR-194-1 | 0.0002901 | 0.0763 |
HSA-MIR-194-2 | 0.0003852 | 0.0763 |
HSA-MIR-192 | 0.0004207 | 0.0763 |
HSA-MIR-10A | 0.0009435 | 0.106 |
HSA-MIR-122 | 0.0009786 | 0.106 |
HSA-MIR-200B | 0.001607 | 0.146 |
HSA-MIR-200A | 0.002081 | 0.149 |
HSA-MIR-101-1 | 0.002192 | 0.149 |
HSA-MIR-375 | 0.002682 | 0.162 |
HSA-MIR-214 | 0.003181 | 0.164 |
Table S15. Basic characteristics of clinical feature: 'COMPLETENESS_OF_RESECTION'
COMPLETENESS_OF_RESECTION | Labels | N |
R0 | 315 | |
R1 | 15 | |
R2 | 1 | |
RX | 20 | |
Significant markers | N = 0 |
Table S16. Basic characteristics of clinical feature: 'RACE'
RACE | Labels | N |
AMERICAN INDIAN OR ALASKA NATIVE | 1 | |
ASIAN | 159 | |
BLACK OR AFRICAN AMERICAN | 17 | |
WHITE | 171 | |
Significant markers | N = 30 |
Table S17. Get Full Table List of top 10 miRs differentially expressed by 'RACE'
kruskal_wallis_P | Q | |
---|---|---|
HSA-MIR-23C | 5.315e-15 | 2.89e-12 |
HSA-MIR-3130-1 | 2.502e-11 | 6.81e-09 |
HSA-MIR-532 | 4.404e-07 | 7.99e-05 |
HSA-MIR-30D | 1.22e-06 | 0.000166 |
HSA-MIR-511-1 | 1.186e-05 | 0.00104 |
HSA-MIR-1304 | 1.277e-05 | 0.00104 |
HSA-MIR-511-2 | 1.339e-05 | 0.00104 |
HSA-MIR-338 | 5.639e-05 | 0.00366 |
HSA-MIR-26B | 6.048e-05 | 0.00366 |
HSA-MIR-627 | 8.05e-05 | 0.00438 |
Table S18. Basic characteristics of clinical feature: 'ETHNICITY'
ETHNICITY | Labels | N |
HISPANIC OR LATINO | 12 | |
NOT HISPANIC OR LATINO | 329 | |
Significant markers | N = 2 | |
Higher in NOT HISPANIC OR LATINO | 2 | |
Higher in HISPANIC OR LATINO | 0 |
Table S19. Get Full Table List of 2 miRs differentially expressed by 'ETHNICITY'
W(pos if higher in 'NOT HISPANIC OR LATINO') | wilcoxontestP | Q | AUC | |
---|---|---|---|---|
HSA-MIR-508 | c("3148", "0.0003382") | c("3148", "0.0003382") | 0.184 | 0.8047 |
HSA-MIR-514-3 | c("1409", "0.0009128") | c("1409", "0.0009128") | 0.248 | 0.8963 |
-
Expresson data file = LIHC-TP.miRseq_RPKM_log2.txt
-
Clinical data file = LIHC-TP.merged_data.txt
-
Number of patients = 358
-
Number of miRs = 544
-
Number of clinical features = 11
-
For clinical features selected for this analysis and their value conozzle.versions, please find a documentation on selected CDEs .
-
Survival time data
-
Survival time data is a combined value of days_to_death and days_to_last_followup. For each patient, it creates a combined value 'days_to_death_or_last_fup' using conversion process below.
-
if 'vital_status'==1(dead), 'days_to_last_followup' is always NA. Thus, uses 'days_to_death' value for 'days_to_death_or_fup'
-
if 'vital_status'==0(alive),
-
if 'days_to_death'==NA & 'days_to_last_followup'!=NA, uses 'days_to_last_followup' value for 'days_to_death_or_fup'
-
if 'days_to_death'!=NA, excludes this case in survival analysis and report the case.
-
if 'vital_status'==NA,excludes this case in survival analysis and report the case.
-
cf. In certain diesase types such as SKCM, days_to_death parameter is replaced with time_from_specimen_dx or time_from_specimen_procurement_to_death .
-
This analysis excluded clinical variables that has only NA values.
For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels
For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R
For two groups (mutant or wild-type) of continuous type of clinical data, wilcoxon rank sum test (Mann and Whitney, 1947) was applied to compare their mean difference using 'wilcox.test(continuous.clinical ~ as.factor(group), exact=FALSE)' function in R. This test is equivalent to the Mann-Whitney test.
For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.
In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.